← Open Payments lookup

ANNE LEACH: Open Payments

NPI 1780661918 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,090 in 133 payments from 18 companies in 2025. Trend: 2023 $1,164 · 2024 $1,347 · 2025 $2,090

Food & beverage: $2,090
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.24$397
Neurocrine BioSciences, Inc.18$283
Alkermes, Inc.16$239
Otsuka America Pharmaceutical, Inc.19$222
E.R. Squibb & Sons, L.L.C.16$193
ABBVIE INC.11$183
Vanda Pharmaceuticals Inc.6$167
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$97
Lundbeck LLC4$69
Noven Therapeutics, LLC3$59

Products named: INGREZZA, UZEDY, ARISTADA, COBENFY, VRAYLAR, FANAPT, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across IN — which companies pay providers there.